Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1143]
News [2510]
Articles [153]
Editorials [8]
Conferences [102]
elearning [18]
Award-winning agent developed for prostate cancer diagnosis and treatment
Award-winning agent developed for prostate cancer diagnosis and treatment
New epigenomic block for advanced cancer progression
New epigenomic block for advanced cancer progression
NICE reject enzalutamide for advanced prostate cancer before chemotherapy
NICE reject enzalutamide for advanced prostate cancer before chemotherapy
Anti-tumor agent can be activated by natural response to cell stress
Anti-tumor agent can be activated by natural response to cell stress
New specialised radiation therapy comes to Namibia
New specialised radiation therapy comes to Namibia
ASCO 2015: Lenvatinib increases progression free survival and overall response rate when used with everolimus in metastatic renal cell carcinoma
ASCO 2015: Lenvatinib increases progression free survival and overall response rate when used with everolimus in...
ASCO 2015: Pembrolizumab may be promising treatment for urothelial cancer
ASCO 2015: Pembrolizumab may be promising treatment for urothelial cancer
Western diet after prostate cancer diagnosis associated with increased risk of death
Western diet after prostate cancer diagnosis associated with increased risk of death
ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer
ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer
ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers
ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation